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Abstract
Glutamate receptors in the basolateral complex of the amygdala (BLA) are essential for the acquisition, expression and extinction of
Pavlovian fear conditioning in rats. Recent work has revealed that glutamate receptors in the central nucleus of the amygdala (CEA)
are also involved in the acquisition of conditional fear, but it is not known whether they play a role in fear extinction. Here we examine
this issue by infusing glutamate receptor antagonists into the BLA or CEA prior to the extinction of fear to an auditory conditioned
stimulus (CS) in rats. Infusion of the a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor antagonist, 2,3-
dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX), into either the CEA or BLA impaired the expression of
conditioned freezing to the auditory CS, but did not impair the formation of a long-term extinction memory to that CS. In contrast,
infusion of the N-methyl-d-aspartate (NMDA) receptor antagonist, d,l-2-amino-5-phosphonopentanoic acid (APV), into the amygdala,
spared the expression of fear to the CS during extinction training, but impaired the acquisition of a long-term extinction memory.
Importantly, only APV infusions into the BLA impaired extinction memory. These results reveal that AMPA and NMDA receptors
within the amygdala make dissociable contributions to the expression and extinction of conditioned fear, respectively. Moreover, they
indicate that NMDA receptor-dependent processes involved in extinction learning are localized to the BLA. Together with previous
work, these results reveal that NMDA receptors in the CEA have a selective role acquisition of fear memory.
Introduction
Pavlovian fear conditioning is an important behavioral paradigm used
to study the neurobiological mechanisms of emotional learning and
memory (Davis, 1992; Fendt & Fanselow, 1999; LeDoux, 2000;
Maren, 2001, 2005a). In this form of conditioning, an animal learns
that a neutral conditioned stimulus (CS), such as a tone, predicts an
aversive unconditioned stimulus (US), such as a footshock. After
conditioning, the CS alone elicits a variety of conditioned fear
responses (CRs), including increases in blood pressure, potentiated
acoustic startle and freezing behavior. Degrading the relationship
between the CS and the US by presenting the CS alone numerous
times results in an extinction of fear to the CS. During extinction,
animals learn a new inhibitory memory that suppresses fear. This
suppression is labile, however, and fear CRs may return with changes
in context (renewal), for example (Maren, 2005a; Bouton et al., 2006).
In recent years, there has been a growing interest in understanding
the neurobiological mechanisms of fear extinction (Maren & Quirk,
2004; Bouton et al., 2006; Corcoran & Quirk, 2007; Myers & Davis,
2007; Quirk & Mueller, 2008). It is now well established that the
basolateral complex of the amygdala (BLA) is crucial for the
acquisition, expression and extinction of conditioned fear (Fendt &
Fanselow, 1999; LeDoux, 2000; Davis & Whalen, 2001; Maren,
2001). Within the BLA, considerable work has revealed an important
role for glutamate receptors in these processes. Specifically, infusions
of a-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptor
(AMPAR) or N-methyl-d-aspartate receptor (NMDAR) antagonists
into the BLA impair the expression of conditioned fear (Miserendino
et al., 1990; Campeau et al., 1992; Maren et al., 1996; Lee & Kim,
1998; Fendt, 2001; Lee et al., 2001; Rodrigues et al., 2001; Goosens
& Maren, 2004; Walker et al., 2005), whereas NMDAR antagonists
prevent the acquisition and extinction of fear (Miserendino et al.,
1990; Campeau et al., 1992; Falls et al., 1992; Cox & Westbrook,
1994; Fanselow & Kim, 1994; Maren et al., 1996; Lee & Kim, 1998;
Rodrigues et al., 2001; Santini et al., 2001; Lin et al., 2003; Goosens
& Maren, 2004; Maren & Quirk, 2004; Walker et al., 2005).
Interestingly, infusions of NMDAR agonists into the BLA facilitate
extinction (Walker et al., 2002).
In addition to the BLA, there is a growing appreciation for the role
played by the central nucleus of the amygdala (CEA) in Pavlovian fear
conditioning. For example, recent work has shown that lesions,
temporary inactivation or NMDAR antagonism of the CEA block the
acquisition of conditioned fear (Goosens & Maren, 2003; Wilensky
et al., 2006; Zimmerman et al., 2007). Furthermore, protein synthesis
inhibition within the CEA immediately after the acquisition of
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conditioned fear blocks the consolidation of the fear memory
(Wilensky et al., 2006). Consistent with the role of the CEA in the
acquisition of fear, Samson & Pare (2005) have demonstrated
NMDAR-dependent plasticity within the CEA in vitro. These findings
suggest the possibility that CEA glutamate receptors, and NMDARs in
particular, have a role in the extinction of fear. Here we address this
issue by comparing the effects of glutamate receptor antagonism in the
BLA and CEA on the extinction of fear to an auditory CS in rats.
Materials and methods
Experiment 1: AMPAR antagonism in the BLA or CEA and fear
extinction
Subjects
The subjects were 53 male Long–Evans rats (200–224 g; Blue Spruce)
obtained from a commercial supplier (Harlan Sprague Dawley,
Indianapolis, IN, USA). After arrival, the animals were individually
housed in clear plastic cages hanging from a standard stainless-steel
rack. The vivarium lights were on a 14 ⁄ 10 h light ⁄ dark cycle (lights
on at 07.00 h), and the rats had free access to food and tap water. After
housing, the rats were handled (15–20 s each) for 5 days to acclimate
them to the experimenter. All experiments were carried out in
accordance with guidelines of the NIH and approved by the University
of Michigan University Committee on Use and Care of Animals.
Behavioral apparatus
Eight identical observation chambers (30 · 24 · 21 cm; Med-Asso-
ciates, St Albans, VT, USA) were used for all phases of training and
testing. The chambers were constructed from aluminum (two side
walls) and Plexiglas (rear wall, ceiling and hinged front door), and
were situated in sound-attenuating chests located in an isolated room.
The floor of each chamber consisted of 19 stainless-steel rods (4 mm
diameter) spaced 1.5 cm apart (center to center). The rods were wired
to a shock source and solid-state grid scrambler (Med-Associates) for
delivery of the footshock US (1.0 mA, 2 s). For ‘context A’ (used for
conditioning), background noise (65 dB) was provided by ventilation
fans built into the chests, house lights within the chambers and
fluorescent lights within the room provided illumination, the chest
doors were left open, the chambers were cleaned with a 1%
ammonium hydroxide solution, and the rats were transported in black
carriers. For ‘context B’ (used for Drug and Drug-Free Extinction),
illumination was provided by incandescent red lights, the chest doors
were closed, the ventilation fans were inactive, the chambers were
cleaned with a 1% acetic acid solution, the floors were covered with
black plastic panels, and the rats were transported in white 5-gallon
buckets. Stainless-steel pans containing a thin film of the correspond-
ing cleaning solutions were placed underneath the grid floors before
the animals were placed inside the boxes.
Each conditioning chamber rested on a load cell platform that was
used to record chamber displacement in response to each rats’ motor
activity. To ensure interchamber reliability, each load cell amplifier
was calibrated to a fixed chamber displacement. The output of the load
cell of each chamber was set to a gain that was optimized for detecting
freezing behavior. Load cell amplifier output from each chamber was
digitized and acquired on-line using Threshold Activity software
(Med-Associates).
Surgery
After handling for at least 5 days, rats were treated with atropine
sulfate (0.4 mg ⁄ kg body weight, i.p.) and sodium pentobarbital
(65 mg ⁄ kg body weight, i.p.), and mounted in stereotaxic apparatus
(David Kopf instruments, Tujunga, CA, USA). The scalp was incised
and retracted, and head position was adjusted to place bregma and
lambda in the same horizontal plane. Small burr holes were drilled
bilaterally in the skull for the placement of 26-gage guide cannula (cut
at 11 mm below the pedestal; Plastics One, Roanoke, VA, USA) in the
BLA (2.8 mm posterior to bregma, 5.0 mm lateral to the midline,
6.3 mm ventral to dura) or CEA (2.5 mm posterior to bregma, 4.3 mm
lateral to the midline, 6.9 mm ventral to the skull surface), and three
small screws. Following implantation dental acrylic was applied to
the skull to hold the cannula in place. After surgery, dummy cannulae
(33-gage, 16 mm; Plastics One) were inserted into the guide cannula,
and the rats were allowed to recover from the anesthesia before being
returned to their home cages. The dummy cannulae were replaced
every other day during the week of recovery.
Procedure
After at least 7 days recovery from surgery, rats were acclimated to the
infusion procedure by transporting them to the infusion room in
identical white 5-gallon buckets in squads of eight (counterbalanced
for each squad and group). Their dummy cannulas were replaced and
the infusion pumps (Harvard Apparatus, South Natick, MA, USA)
were activated. After 5 min, the pumps were stopped and the animals
were returned to their home cages. Twenty-four hours after acclima-
tion, on the conditioning day, the rats were transported to the
laboratory in squads of eight and placed in the conditioning chambers.
The chamber position was counterbalanced for each squad and group.
The rats received five tone (80 dB, 10 s, 2 kHz)–shock (1.0 mA,
2.0 s) pairings (70-s intertrial interval) beginning 3 min after being
placed in the chamber and ending 60 s after the final shock (context
A). The rats were then transported back to their home cages. Twenty-
four hours after training, the rats were transported to the infusion room
as described above and infused with the AMPAR antagonist 2,3-
dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione [NBQX;
2.5 lg in 0.25 lL of 100 mm phosphate-buffered saline (PBS) for the
CEA or 5.0 lg in 0.5 lL of 100 mm PBS for the BLA at 0.1 lL ⁄ min]
or 100 mm PBS (VEH; 0.25 lL for the CEA or 0.5 lL for the BLA at
0.1 lL ⁄ min). After the infusion, 1 min was allowed for diffusion
before removing the internal cannula. After removing the internal
cannulae, clean dummy cannulae were inserted into the guide cannula
and rats were immediately transported to the conditioning chambers
for Drug Extinction. Extinction consisted of 45 CS-alone presentations
(80 dB, 10 s, 2 kHz) with a 30-s intertrial interval beginning 3 min
after being placed in the chamber and ending 3 min after the final CS
presentation for rats in the extinction groups (BLA-NBQX-E, CEA-
NBQX-E, VEH-E; context B). During the Drug Extinction session,
rats in the no-extinction group (VEH-NE) were placed in the
conditioning chamber for the same amount of time as the extinction
groups in the absence of any CS presentations (context B). Forty-eight
hours after training the rats were transported to the conditioning
chambers for Drug-Free Extinction (context B). Drug-Free Extinction
was identical to the Drug Extinction performed 24 h prior (all groups
received CS presentations).
During the training and extinction sessions, each rat’s activity was
monitored continuously using the data acquisition software described
above. For each chamber, load cell activity was digitized at 5 Hz,
yielding one observation per rat every 200 ms (300 observa-
tions ⁄ rat ⁄ min). Load cell values ranged between 0 and 100, and this
value was used to quantify locomotor activity. Freezing was quantified
by computing the number of observations for each rat that had a load
cell value less than the freezing threshold (threshold = 10). The
freezing threshold was determined in a separate group of pilot animals
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by comparing load cell output with an observer’s rating of freezing
behavior. To avoid counting momentary inactivity as freezing, an
observation was only scored as freezing if it fell within a contiguous
group of at least five observations that were all less than the freezing
threshold. Thus, freezing was only scored if the rat was immobile for
at least 1 s. For each session, the freezing observations were
transformed to a percentage of total observations. In the present
experiment, freezing was quantified before footshock during the pre-
trial period and after footshock offset on the conditioning day, and
throughout the entirety of the extinction tests.
Histology
Histological verification of cannula placements was performed after
behavioral testing. Rats were killed with CO2 asphyxiation followed
by decapitation. After extraction from the skull, the brains were fixed
in 10% formalin for at least 2 days, followed by 10% formalin and
30% sucrose until sectioning. Coronal sections (45 lm thick, taken
every 135 lm) were cut on a cryostat ()20 C) and wet-mounted on
glass microscope slides with 70% ethanol. After drying, the sections
were stained with 0.25% thionin to visualize neuronal cell bodies.
Placements were verified by visual inspection of the stained brain
sections.
Data analysis
For each session, the freezing data were transformed to a percentage of
total observations, a probability estimate that is amenable to analysis
with parametric statistics. These probability estimates of freezing were
analysed using analysis of variance (anova). Post hoc comparisons in
the form of Fisher’s PLSD tests were performed after a significant
overall F-ratio. All data are represented as means ± SEMs.
Experiment 2: NMDAR antagonism in the BLA or CEA and fear
extinction
Subjects
The subjects were 60 male Long–Evans rats (200–224 g; Blue Spruce)
obtained and housed as described in Experiment 1.
Apparatus, surgery, procedure, histology and data analysis
All materials and methods are as described in Experiment 1, except
that rats were infused with the NMDAR antagonist d,l-2-amino-5-
phosphonopentanoic acid (APV; 2.5 lg in 0.25 lL of 100 mm PBS
for the CEA or 5.0 lg in 0.5 lL of 100 mm PBS for the BLA at
0.1 lL ⁄ min) or 100 mm PBS (VEH; 0.25 lL for the CEA or 0.5 lL
for the BLA at 0.1 lL ⁄ min).
Results
Experiment 1: AMPAR antagonism in the BLA or CEA prevents
the expression, but not extinction, of conditioned fear
Histology
Based on histological results, 53 rats were included in this experiment.
Rats were excluded if their guide cannulae were located outside the
intended structure. This yielded the following group sizes: rats
receiving NBQX in the BLA during extinction (BLA-NBQX-E;
n = 12), rats receiving NBQX in the CEA during extinction (CEA-
NBQX-E; n = 12), rats receiving PBS in the BLA or CEA during
extinction, were not statistically different and were collapsed into a
single group (VEH-E; n = 18), and rats receiving PBS in the BLA or
CEA that did not receive extinction, were not statistically different and
were collapsed into a single group (VEH-NE; n = 11). BLA and CEA
cannula placements for rats included in the analysis are depicted in
Fig. 1. All cannula placements were located within the intended
structures (BLA or CEA).
Behavior
Post-shock freezing during the conditioning session is shown in
Fig. 2A. Freezing was not statistically different across groups. The
data were analysed using two-way anova with variables of group
(BLA-NBQX-E, CEA-NBQX-E, VEH-E, VEH-NE) and trial (1–5).
During the pre-trial period rats displayed minimal levels of freezing
(< 10%). After the onset of conditioning rats displayed increased
levels of freezing. The anova revealed no main effect of group
(F3,49 = 0.97; P = 0.42) or a group · trial interaction (F12,196 = 1.11;
P = 0.35). Additionally, the anova revealed a main effect of trial
(F4,196 = 12.38; P < 0.0001). This indicates that the average level of
freezing across the training session was not significantly different
between the groups. However, the groups increased their freezing as
the training session proceeded.
Twenty-four hours after training, rats were infused with either VEH
or NBQX immediately before Drug Extinction. Freezing during the
Drug Extinction test is shown in Fig. 2B. Before CS onset, all groups
showed low levels of freezing (similar to those seen during the pre-
period of training). A two-way anova with variables of group (BLA-
NBQX-E, CEA-NBQX-E, VEH-E, VEH-NE) and trial (1–45)
revealed a significant main effect of group (F3,49 = 6.89; P =
0.0006), trial (F44,2156 = 2.80; P < 0.0001), and a group · trial
interaction (F132,2156 = 5.02; P < 0.0001). Post hoc analysis of the
main effect of group revealed that rats receiving NBQX in the BLA or
CEA (BLA-APV-E, CEA-NBQX-E) froze significantly less than the
rats receiving VEH during extinction (VEH-E; P < 0.02 for both
comparisons). Additionally, rats receiving VEH before extinction
(VEH-E) froze significantly more than rats receiving VEH without
Fig. 1. Schematic representation showing the discrete locations of the internal
cannula used to infuse saline (squares) or drug (APV or NBQX; circles).
Coronal brain section images adapted from Swanson (1992).
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extinction (VEH-NE; P = 0.0003). There were no significant differ-
ences between rats receiving NBQX in the BLA (BLA-NBQX-E), rats
receiving NBQX in the CEA (CEA-NBQX-E) or rats receiving
vehicle without extinction (VEH-NE). Importantly, these results
demonstrate that rats receiving NBQX in the BLA or CEA were
unable to express conditional fear to the auditory CS earned 24 h
earlier.
The long-term extinction memory acquired during the Drug
Extinction session was tested 24 h later by exposing the rats to a
second Drug-Free Extinction session. The results from the Drug-Free
Extinction session are shown in Fig. 2C. A two-way anova with
variables of group (BLA-NBQX-E, CEA-NBQX-E, VEH-E, VEH-
NE) and trial (1–45) revealed a significant main effect of group
(F3,49 = 3.13; P < 0.04), trial (F44,2156 = 7.06; P < 0.0001), and
group · trial interaction (F132,2156 = 2.12; P < 0.0001). Post hoc
analysis of the main effect of group revealed that rats receiving NBQX
in the BLA (BLA-NBQX-E) or CEA (CEA-NBQX-E) froze signif-
icantly less than rats receiving VEH without extinction (VEH-NE;
P < 0.03 for both comparisons). Further analysis of the first 10 trials of
the Drug-Free Extinction session via two-way anova with variables of
group (BLA-APV-E, CEA-APV-E, VEH-E, VEH-NE) and trial (1–10)
revealed a significant main effect of group (F3,49 = 4.56; P < 0.007)
and trial (F9,441 = 8.04; P < 0.0001). The group · trial interaction was
not significant (F27,441 = 1.36; P = 0.11). Post hoc analysis of the
main effect of group revealed that rats that did not receive extinction
during the Drug Extinction session (VEH-NE) froze significantly more
than all other groups (P = 0.008 for all comparisons). These results
indicate that while rats receiving NBQX in the BLA or CEA were
unable to express freezing during the Drug Extinction session
(Fig. 2B), they were still able to acquire an extinction memory as
tested during the Drug-Free Extinction session (Fig. 2C).
Experiment 2: NMDAR antagonism in the BLA, but not the CEA,
prevents the extinction of conditioned fear
Histology
Based on histological results, 60 rats were included in this experiment.
Rats were excluded if their guide cannulae were located outside the
intended structure. This yielded the following group sizes: rats receiving
APV in the BLA during extinction (BLA-APV-E; n = 9), rats receiving
APV in the CEA during extinction (CEA-APV-E; n = 10), rats
receiving PBS in the BLA or CEA during extinction, were not
statistically different and were collapsed into a single group (VEH-E;
n = 23), and rats receiving PBS in the BLA or CEA that did not receive
extinction, were not statistically different and were collapsed into a









































































Fig. 2. Conditioned freezing in rats receiving AMPAR inactivation during
extinction (Experiment 1). (A) Mean percentage of freezing (±SEM) during the
five-trial training session (data are displayed with a 3-min pre-trial period
followed by five tone–shock pairings). Freezing was quantified before the first
conditioning trial (Pre) and during the 1-min period after each conditioning
trial. (B) Mean percentage of freezing (±SEM) during the drug extinction
session immediately after drug infusions. Data are displayed with a 3-min pre-
trial period followed by nine bins consisting of five CS alone presentations and
a 2-min post-trial period. Data were quantified before the first CS presentation
(Pre), during each subsequent trial consisting of the 10-s tone presentation and
30-s inter-trial interval, and during the 2-min post-trial period. Rats in the no-
extinction group (NE) were placed in the chambers for the same time period as
all other rats, however, received no CS presentations. (C) Mean percentage of
freezing (±SEM) during the drug-free extinction session. Data are displayed
and quantified as described in (B), with the exception of the NE rats, which
received the same CS presentation as all other rats. Data are shown for
rats receiving 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-di-
one (NBQX) in the basolateral complex of the amygdala (BLA) and CS
presentations during the drug extinction session (open circle), rats receiving
NBQX in the central amygdala (CEA) and CS presentation during the drug
extinction session (closed circle), rats receiving VEH in the BLA or CEA and
CS presentations during the drug extinction session (open square), and rats
receiving VEH in the BLA or CEA and no CS presentations during drug
extinction (closed square).
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rats included in the analysis are depicted in Fig. 1. All cannula
placements were located within the intended structures (BLA or CEA).
Behavior
Post-shock freezing during the conditioning session is shown in
Fig. 3A. Freezing was not statistically different across groups. The
data were analysed using two-way anova with variables of group
(BLA-APV-E, CEA-APV-E, VEH-E, VEH-NE) and trial (1–5).
During the pre-trial period rats displayed minimal levels of freezing
(< 10%). After the onset of conditioning rats displayed potentiated
freezing. The anova revealed no main effect of group (F3,56 = 1.9;
P = 0.14). Additionally, the anova revealed a main effect of trial
(F4,224 = 20.1; P < 0.0001), and a group · trial interaction
(F12,224 = 2.25; P = 0.01). This indicates that the average level of
freezing across the training session was not significantly different
between the groups. However, the groups increased their freezing as
the training session proceeded and did so at different rates.
Twenty-four hours after training rats were infused with either VEH
or APV immediately before Drug Extinction. Freezing during the
Drug Extinction test is shown in Fig. 3B. Before CS onset, all groups
showed low levels of freezing (similar to those seen during the pre-
period of training). A two-way anova with variables of group (BLA-
APV-E, CEA-APV-E, VEH-E, VEH-NE) and trial (1–45) revealed a
significant main effect of group (F3,56 = 4.42; P < 0.008), trial
(F44,2464 = 1.58; P < 0.01), and a group · trial interaction
(F132,2464 = 2.41; P < 0.0001). Post hoc analysis of the main effect
of group revealed that rats receiving APV in the BLA (BLA-APV-E)
froze significantly more than all other groups (P < 0.03 for all
comparisons). There were no significant differences between the other
groups.
The long-term extinction memory acquired during the Drug
Extinction session was tested 24 h later by exposing the rats to a
second Drug-Free Extinction session. The Drug-Free Extinction
session is shown in Fig. 3C. A two-way anova with variables of
group (BLA-APV-E, CEA-APV-E, VEH-E, VEH-NE) and trial (1–45)
revealed a significant main effect of group (F3,56 = 10.23;
P < 0.0001), trial (F44,2464 = 18.07; P < 0.0001), and group · trial
interaction (F132,2464 = 4.67; P < 0.0001). Post hoc analysis of the
main effect of group revealed that rats in the BLA-APV-E group froze
significantly more than rats in the CEA-APV-E group (P < 0.02).
Additionally, rats in the CEA-APV-E and VEH-E groups froze
significantly less than rats in the VEH-NE group (P < 0.0001 for both
comparisons). Further analysis of the first 10 trials of the Drug-Free
Extinction session via two-way anova with variables of group (BLA-
APV-E, CEA-APV-E, VEH-E, VEH-NE) and trial (1–10) revealed a
significant main effect of group (F3,56 = 17.74; P < 0.0001), trial
(F9,504 = 13.43; P < 0.0001), and a group · trial interaction










































































Fig. 3. Conditioned freezing in rats receiving NMDAR inactivation during
extinction (Experiment 2). (A) Mean percentage of freezing (±SEM) during the
five-trial training session (data are displayed with a 3-min pre-trial period
followed by five tone–shock pairings). Freezing was quantified before the first
conditioning trial (Pre) and during the 1-min period after each conditioning
trial. (B) Mean percentage of freezing (±SEM) during the drug extinction
session immediately after drug infusions. Data are displayed with a 3-min pre-
trial period followed by nine bins consisting of five CS alone presentations and
a 2-min post-trial period. Data were quantified before the first CS presentation
(Pre), during each subsequent trial consisting of the 10-s tone presentation and
30-s inter-trial interval, and during the 2-min post-trial period. Rats in the no-
extinction group (NE) were placed in the chambers for the same time period as
all other rats, however, received no CS presentations. (C) Mean percentage of
freezing (±SEM) during the drug-free extinction session. Data are displayed
and quantified as described in (B), with the exception of the NE rats, which
received the same CS presentation as all other rats. Data are shown for rats
receiving d,l-2-amino-5-phosphonopentanoic acid (APV) in the basolateral
complex of the amygdala (BLA) and CS presentations during the drug
extinction session (open circle), rats receiving APV in the central amygdala
(CEA) and CS presentation during the drug extinction session (closed circle),
rats receiving VEH in the BLA or CEA and CS presentations during the drug
extinction session (open square), and rats receiving VEH in the BLA or CEA
and no CS presentations during drug extinction (closed square).
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group revealed that rats in the BLA-APV-E and VEH-NE groups froze
significantly more than rats in the CEA-APV-E and VEH-E groups
(P < 0.0001 for all comparisons). Importantly, rats in the BLA-APV-E
group and VEH-NE group were not significantly different (P = 0.71),
indicating that rats with BLA NMDAR antagonism had no memory of
the extinction session that occurred 24 h earlier. Additionally, rats in
the CEA-APV-E groups and VEH-E were not significantly different
(P = 0.37) from one another. This indicates that NMDAR antagonism
within the CEA had no effect on the formation of a long-term memory
for extinction.
Discussion
The present experiments demonstrate distinct roles for AMPARs and
NMDARs in the BLA and CEA in the expression and extinction of
conditioned fear. We show that AMPARs within both the BLA and
CEA are necessary for the expression of conditioned fear, but are not
required for fear extinction. In contrast, NMDAR antagonism in the
amygdala did not influence the expression of fear but did impair the
acquisition of extinction. Importantly, the effect of NMDAR antag-
onism on extinction learning was only obtained with intra-BLA
infusions of APV; antagonism of CEA NMDARs did not affect the
expression or extinction of fear.
Consistent with previous reports, we found that AMPARs in the
BLA are involved in the expression of conditional fear (Falls et al.,
1992; Kim et al., 1993; Walker et al., 2005). We now show that
AMPARs in the CEA are also involved in the expression of
conditioned freezing. Interestingly, NMDARs in the BLA and CEA
were not involved in the expression of conditioned fear. This is
consistent with other studies in which normal fear responses were
reported after NMDAR antagonism in the BLA (Miserendino et al.,
1990; Campeau et al., 1992; Rodrigues et al., 2001; Walker et al.,
2005). However, these data stand in contrast to several reports,
including an earlier report from our laboratory, that NMDAR
antagonism in the BLA prevents the expression of fear (Maren et al.,
1996; Lee & Kim, 1998; Fendt, 2001; Lee et al., 2001; Goosens &
Maren, 2004). In our earlier report, we used a contextual conditioning
paradigm, whereas in the present study we assessed fear to an auditory
CS. It is possible that amygdala NMDARs are differently involved in
the expression of fear to contexts and cues.
Alternatively differences in the contribution of NMDAR subtypes
to fear expression (Walker & Davis, 2008) and the influence of
different APV enantiomers on these subtypes (Matus-Amat et al.,
2007) might contribute to the variable effects of NMDAR antagonists
in the expression of fear. While both the BLA and CEA contain
NMDARs, the NMDAR subunit composition within these areas is
different and therefore differentially susceptible to various NMDAR
antagonists. NMDARs form heteromultimers containing an NR1
subunit and a combination of NR2A and ⁄ or NR2B subunits (Cull-
Candy et al., 2001; Prybylowski & Wenthold, 2004). A recent in vitro
electrophysiological study of NMDARs in the BLA and CEA reveals
that the NMDAR-mediated currents in CEA neurons have slow
kinetics and are blocked by NR2B-specific antagonists, suggesting
that they are composed of the NR1 ⁄ NR2B subunits (Lopez de
Armentia & Sah, 2003). In contrast, NMDAR currents in BLA
neurons demonstrate much faster kinetics and are less sensitive to
NR2B-specific antagonists. This suggests that they are composed
mostly of the NR1 ⁄ NR2A subunits (Lopez de Armentia & Sah, 2003).
Consistent with this, Walker & Davis (2008) have demonstrated that
infusions of an NR2A antagonist (NVP-AAM077) into the BLA
blocked both fear conditioning and expression, whereas an NR2B
antagonist (CP101, 606) disrupted conditioning but not expression. It
is therefore possible that a more selective NR2B-specific antagonist,
such as ifenprodil, would lead to an extinction impairment when
infused into the CEA.
Although APV did not impair the expression of fear, it did produce
a robust attenuation of extinction learning when infused into the BLA.
This outcome confirms numerous reports indicating the importance of
BLA NMDARs in extinction learning (Falls et al., 1992; Cox &
Westbrook, 1994; Santini et al., 2001; Walker et al., 2002; Lin et al.,
2003; Maren & Quirk, 2004; Sotres-Bayon et al., 2007). Together,
these data provide strong support to the view that NMDAR-dependent
plasticity in the BLA is involved in both the acquisition and extinction
of fear conditioning (Davis, 2002; Maren, 2005b; Quirk & Mueller,
2008). To our surprise, however, APV infusions into the CEA did not
impair extinction learning, even though they severely attenuate fear
conditioning when infused prior to training (Goosens & Maren, 2003).
This finding provides unique insight into the specific neurocircuitry
underlying extinction and draws a stark contrast between the role of
NMDARs in the BLA and CEA in conditioning and extinction.
Indeed, our findings here suggest a dissociation between the role of the
CEA in the acquisition and extinction of fear. While NMDAR
antagonism within CEA blocks the acquisition of conditioned fear
(Maren et al., 1996; Goosens & Maren, 2003, 2004), it had no effect
on the acquisition of extinction (Experiment 2). While this result is
surprising, it is not without precedent. Bahar et al. (2003) found that
infusion of a protein synthesis inhibitor into the CEA blocked the
acquisition of conditioned taste aversion (CTA), while having no
effect on the extinction of CTA. Collectively, these data suggest that
NMDAR-dependent plasticity in the CEA (Wilensky et al., 2006) has
a selective role in fear acquisition, whereas BLA plasticity has a
broader role in acquiring both fear and extinction memories.
Although NMDAR-dependent plasticity in the CEA is not involved
in extinction learning, there is considerable evidence that the
regulation of neuronal activity in the CEA is importantly involved
in the expression of extinction. Indeed, recent data indicate that a
network of c-aminobutyric acid (GABA)ergic inhibitory interneurons
in the amygdala are involved in the expression of extinction (Likhtik
et al., 2008). These intercalated neurons (ITC) receive input from both
the lateral amygdala and the medial prefrontal cortex, and strongly
inhibit the CEA. Given the evidence linking the medial prefrontal
cortex to the expression of extinction (Quirk et al., 2000; Santini
et al., 2001, 2004; Maren & Quirk, 2004; Pare et al., 2004; Sotres-
Bayon et al., 2007; Quirk & Mueller, 2008; Knapska & Maren, 2009),
it is widely believed that medial prefrontal cortical projections to the
ITC and consequent inhibition of CEA activity is involved in the
expression of extinction.
In conclusion, while both the CEA and BLA are necessary for the
acquisition and expression of Pavlovian conditioned fear (Wilensky
et al., 2006; Zimmerman et al., 2007), we now show distinct roles for
AMPARs and NMDARs within the BLA and CEA in the expression
of conditional fear and the acquisition of extinction. AMPARs in both
the BLA and CEA are involved in the expression of fear, but are not
required for fear extinction. In contrast, NMDARs are necessary for
the extinction, but not expression, of fear. Importantly, only BLA
NMDARs are involved in extinction learning. These findings provide
important insight into the molecular mechanisms that underlie
extinction and help to further refine the intra-amygdaloid circuitry
that underlies conditioned fear.
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